Secondary prevention of cardiovascular diseases in India: Findings from registries and large cohorts

Hasan Rehman1, Ankur Kalra2, Ajar Kochar3

  • 1Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, TX, USA.

Indian Heart Journal
|November 15, 2020
PubMed

Insights

Several Indian registries and quality improvement programs focus on cardiovascular disease (CVD) secondary prevention. Initiatives like TN-STEMI and ACS-QUIK aim to improve patient care and outcomes, highlighting the need for data-driven policy.

Area of Science:

  • Cardiovascular disease research
  • Public health initiatives in India
  • Quality improvement in healthcare

Background:

  • Cardiovascular disease (CVD) poses a significant health burden in India.
  • Existing registries and quality improvement programs aim to address secondary prevention of CVD.
  • Various initiatives have been implemented to assess and enhance CVD care across India.

Purpose of the Study:

  • To review existing registries and quality improvement initiatives for secondary CVD prevention in India.
  • To evaluate the scope and impact of programs like CREATE, IHRS-AF, THF, TN-STEMI, ACS-QUIK, and PIQIP.
  • To identify the need for collaborative efforts and data utilization in CVD policy-making.

Main Methods:

  • Analysis of data from established Indian registries (CREATE, IHRS-AF, THF).
  • Examination of quality improvement programs focusing on acute coronary syndromes and CVD.
  • Review of initiatives aimed at improving revascularization access and outpatient care quality.

Main Results:

  • Registries like CREATE, IHRS-AF, and THF primarily focus on data collection.
  • The TN-STEMI program specifically targets improving revascularization access post-STEMI.
  • ACS-QUIK assessed a quality improvement kit for ACS, and PIQIP provides data on outpatient CVD care.

Conclusions:

  • Multiple initiatives exist to improve secondary CVD prevention in India, with varying focuses.
  • There is a need for enhanced collaboration among health professionals to identify knowledge and policy gaps.
  • Effective utilization of existing and new data by policymakers is crucial for driving impactful CVD prevention strategies.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
492
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
694
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
203
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
621
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.4K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
265